December 6-10, 2009
Fairmont Orchid
Kohala Coast (Big Island), Hawaii, USA
www.hepdart.com
ABSTRACT SUBMISSION AND EARLY REGISTRATION DEADLINE: FRIDAY, OCTOBER 2, 2009
This year's meeting will be held at the Fairmont Orchid on the Big Island of Hawaii from December 6-10, 2009, celebrating 20 years of HCV Research. Registration to this meeting is limited to 400 persons, with priority given to those submitting an accepted abstract (deadline for abstract submission is October 2, 2009).
ABSTRACT SUBMISSION
Abstract submission is via an online process. For abstract guidelines and to submit an abstract, please click below:
www.hepdart.com
ABSTRACT CATEGORIES
Advances in HCV and HBV Cell-based Assays & Animal Models
Clinical Development of HBV/HCV Inhibitors
Co-infection with HIV and Other Viruses
Hepatocellular Carcinoma and Fibrosis
Immunology & Vaccine Development
Next Generation of HBV and HCV Inhibitors
New Therapeutic Approaches, Combinations, Pharmacology, and Emerging Targets
Optimizing Outcome of Therapeutics for HBV/HCV
Pathogenesis, Therapeutics, Viral Dynamics and Emerging Viruses
Resistance to Antiviral Agents, Replication Fitness and Vaccine Escape Mutants
Diagnostic Approaches and Non-invasive Markers
ONLINE REGISTRATION
Please take advantage of the discounted registration fee for early registration and register on or before October 2, 2009.
For more information regarding the HEP DART 2009 meeting, please find below a link to the brochure. Simply click on the picture below and it will open the entire brochure in your web browser window.
I appreciate your forwarding this email to anyone who might be interested in attending this meeting. If you have any questions, please contact the Conference Secretariat at: hepdart2009@informedhorizons.com. We look forward to seeing you in Hawaii in December.
On behalf of the Organizing Committee
Raymond F. Schinazi, Emory University/VA Medical Center, USA
Robert Murphy, Northwestern University, USA
Charles Rice, The Rockefeller University, USA
Eugene Schiff, University of Miami, USA
About Me
.jpg)
- Scott Weinstein
- Brooklyn, New York, United States
- I'm Hep C positive for over 40 years and have been on treatment three times. Once it was with weekly shots of Peginterferon and 6 Ribavirin pills daily for 8 months, next it was Pegasys two shots weekly with 6 Ribavirin pills daily and a shot of Procrit each week for 8 months and lastly daily shots of Infergen with 6 Ribavirin pills daily and two shots of Procrit weekly. I am a true non-responder. This is for those thinking about going on treatment, family and friends of those with Hepatitis and non-responders wondering what the future holds. Let me add that the future does hold good news for those of us who have been like myself, there is hope out there with Protease Inhibitors etc even for those like myself who have become Cirrhotic. I have been a member of a Liver Support group at Mt. Sinai Hospital in New York City for the last four years and have done some work with the New York City Dept. of Health, the New York State Dept. of Health, the New York City Harlem Task Force for HCV, their Pathways Subcommittee Group and recently have gone to speak to Assembly persons on the New York State Legislature to try and get a bill passed for funding for HCV awareness in New York State.
Scott
At Home
My Baby
.JPG)
Maximus a Cane Corso
No comments:
Post a Comment